• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
First Mildly Ill, Nonhospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States-Maricopa County, Arizona, 2020.美国亚利桑那州马里科帕县 2020 年首例无病毒传播的 2019 年冠状病毒病(COVID-19)轻度发病、未住院病例。
Clin Infect Dis. 2020 Jul 28;71(15):807-812. doi: 10.1093/cid/ciaa374.
2
Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States.美国九例早期旅行相关 SARS-CoV-2 病例的强化接触者调查。
PLoS One. 2020 Sep 2;15(9):e0238342. doi: 10.1371/journal.pone.0238342. eCollection 2020.
3
A preliminary study on contact tracing & transmission chain in a cluster of 17 cases of severe acute respiratory syndrome coronavirus 2 infection in Basti, Uttar Pradesh, India.印度北方邦巴斯蒂 17 例严重急性呼吸综合征冠状病毒 2 感染聚集性病例的接触者追踪和传播链初步研究。
Indian J Med Res. 2020;152(1 & 2):95-99. doi: 10.4103/ijmr.IJMR_2914_20.
4
First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA.美国首例人传人严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)。
Lancet. 2020 Apr 4;395(10230):1137-1144. doi: 10.1016/S0140-6736(20)30607-3. Epub 2020 Mar 13.
5
Detection of SARS-CoV-2 RNA and Antibodies in Diverse Samples: Protocol to Validate the Sufficiency of Provider-Observed, Home-Collected Blood, Saliva, and Oropharyngeal Samples.在不同样本中检测 SARS-CoV-2 RNA 和抗体:验证提供者观察、家庭采集的血液、唾液和口咽样本是否充足的方案。
JMIR Public Health Surveill. 2020 Apr 24;6(2):e19054. doi: 10.2196/19054.
6
Investigation and Serologic Follow-Up of Contacts of an Early Confirmed Case-Patient with COVID-19, Washington, USA.美国华盛顿州一起早期确诊病例患者接触者的调查和血清学随访
Emerg Infect Dis. 2020 Aug;26(8):1671-1678. doi: 10.3201/eid2608.201423. Epub 2020 May 29.
7
Transmission risk of SARS-CoV-2 to healthcare workers -observational results of a primary care hospital contact tracing.SARS-CoV-2 对医护人员的传播风险-基层医疗机构接触者追踪的观察结果。
Swiss Med Wkly. 2020 Apr 25;150:w20257. doi: 10.4414/smw.2020.20257. eCollection 2020 Apr 20.
8
Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.中国武汉医护人员家庭接触者中的无症状 SARS-CoV-2 感染。
Emerg Infect Dis. 2020 Aug;26(8):1930-1933. doi: 10.3201/eid2608.201016. Epub 2020 Apr 24.
9
First 100 Persons with COVID-19 - Zambia, March 18-April 28, 2020.2020 年 3 月 18 日至 4 月 28 日,赞比亚首批 100 例新冠肺炎病例。
MMWR Morb Mortal Wkly Rep. 2020 Oct 23;69(42):1547-1548. doi: 10.15585/mmwr.mm6942a5.
10
Building an "Army of Disease Detectives" to Trace COVID-19 Contacts.组建一支“疾病侦探部队”来追踪新冠病毒接触者。
JAMA. 2020 Jun 16;323(23):2357-2360. doi: 10.1001/jama.2020.8880.

引用本文的文献

1
Missing science: A scoping study of COVID-19 epidemiological data in the United States.缺失的科学:美国 COVID-19 流行病学数据的范围研究。
PLoS One. 2022 Oct 12;17(10):e0248793. doi: 10.1371/journal.pone.0248793. eCollection 2022.
2
Presymptomatic, asymptomatic and post-symptomatic transmission of SARS-CoV-2: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的症状前、无症状和症状后传播:英国感染协会(BIA)、医疗保健感染协会(HIS)、感染预防协会(IPS)和皇家病理学家学院(RCPath)联合指南
BMC Infect Dis. 2022 May 12;22(1):453. doi: 10.1186/s12879-022-07440-0.
3
Molecularly Imprinted Polymer Nanoparticles Enable Rapid, Reliable, and Robust Point-of-Care Thermal Detection of SARS-CoV-2.分子印迹聚合物纳米粒子实现了 SARS-CoV-2 的即时、可靠和稳健的现场热检测。
ACS Sens. 2022 Apr 22;7(4):1122-1131. doi: 10.1021/acssensors.2c00100. Epub 2022 Apr 13.
4
Modelling upper respiratory viral load dynamics of SARS-CoV-2.模拟 SARS-CoV-2 上呼吸道病毒载量动力学。
BMC Med. 2022 Jan 13;20(1):25. doi: 10.1186/s12916-021-02220-0.
5
Clinical characteristics and symptom duration among outpatients with COVID-19.COVID-19 门诊患者的临床特征和症状持续时间。
Am J Infect Control. 2022 Apr;50(4):383-389. doi: 10.1016/j.ajic.2021.10.039. Epub 2021 Nov 13.
6
SARS-CoV-2 routes of transmission and recommendations for preventing acquisition: joint British Infection Association (BIA), Healthcare Infection Society (HIS), Infection Prevention Society (IPS) and Royal College of Pathologists (RCPath) guidance.严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)传播途径及预防感染建议:英国感染协会(BIA)、医疗保健感染学会(HIS)、感染预防学会(IPS)和皇家病理学家学院(RCPath)联合指南
J Hosp Infect. 2021 Aug;114:79-103. doi: 10.1016/j.jhin.2021.04.027. Epub 2021 May 1.
7
Determining the communicable period of SARS-CoV-2: A rapid review of the literature, March to September 2020.确定 SARS-CoV-2 的传染期:2020 年 3 月至 9 月文献快速回顾。
Euro Surveill. 2021 Apr;26(14). doi: 10.2807/1560-7917.ES.2021.26.14.2001506.
8
Towards a sensitive and accurate interpretation of molecular testing for SARS-CoV-2: a rapid review of 264 studies.面向 SARS-CoV-2 分子检测的敏感且准确解读:264 项研究的快速综述。
Euro Surveill. 2021 Mar;26(10). doi: 10.2807/1560-7917.ES.2021.26.10.2001134.
9
The role of asymptomatic and pre-symptomatic infection in SARS-CoV-2 transmission-a living systematic review.无症状和症状前感染在 SARS-CoV-2 传播中的作用——一项实时系统评价。
Clin Microbiol Infect. 2021 Apr;27(4):511-519. doi: 10.1016/j.cmi.2021.01.011. Epub 2021 Jan 21.
10
Prediction of COVID-19 Patients at High Risk of Progression to Severe Disease.预测 COVID-19 患者发展为重症的高风险。
Front Public Health. 2020 Nov 24;8:574915. doi: 10.3389/fpubh.2020.574915. eCollection 2020.

美国亚利桑那州马里科帕县 2020 年首例无病毒传播的 2019 年冠状病毒病(COVID-19)轻度发病、未住院病例。

First Mildly Ill, Nonhospitalized Case of Coronavirus Disease 2019 (COVID-19) Without Viral Transmission in the United States-Maricopa County, Arizona, 2020.

机构信息

Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Maricopa County Department of Public Health, Phoenix, Arizona, USA.

出版信息

Clin Infect Dis. 2020 Jul 28;71(15):807-812. doi: 10.1093/cid/ciaa374.

DOI:10.1093/cid/ciaa374
PMID:32240285
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7184399/
Abstract

BACKGROUND

Coronavirus disease 2019 (COVID-19) causes a range of illness severity. Mild illness has been reported, but whether illness severity correlates with infectivity is unknown. We describe the public health investigation of a mildly ill, nonhospitalized COVID-19 case who traveled to China.

METHODS

The case was a Maricopa County resident with multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-positive specimens collected on 22 January 2020. Contacts were persons exposed to the case on or after the day before case diagnostic specimen collection. Contacts were monitored for 14 days after last known exposure. High-risk contacts had close, prolonged case contact (≥ 10 minutes within 2 m). Medium-risk contacts wore all US Centers for Disease Control and Prevention-recommended personal protective equipment during interactions. Nasopharyngeal and oropharyngeal (NP/OP) specimens were collected from the case and high-risk contacts and tested for SARS-CoV-2.

RESULTS

Paired case NP/OP specimens were collected for SARS-CoV-2 testing at 11 time points. In 8 pairs (73%), ≥ 1 specimen tested positive or indeterminate, and in 3 pairs (27%) both tested negative. Specimens collected 18 days after diagnosis tested positive. Sixteen contacts were identified; 11 (69%) had high-risk exposure, including 1 intimate contact, and 5 (31%) had medium-risk exposure. In total, 35 high-risk contact NP/OP specimens were collected for SARS-CoV-2 testing; all 35 pairs (100%) tested negative.

CONCLUSIONS

This report demonstrates that SARS-CoV-2 infection can cause mild illness and result in positive tests for up to 18 days after diagnosis, without evidence of transmission to close contacts. These data might inform public health strategies to manage individuals with asymptomatic infection or mild illness.

摘要

背景

2019 年冠状病毒病(COVID-19)可引起多种严重程度的疾病。据报道,轻症病例存在,但尚不清楚疾病严重程度是否与传染性相关。我们描述了对一名前往中国的轻症非住院 COVID-19 病例进行的公共卫生调查。

方法

该病例为马里科帕县居民,2020 年 1 月 22 日采集了多个严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)阳性标本。接触者是在病例诊断标本采集前一天或当天接触过病例的人。接触者在最后一次已知接触后监测 14 天。高风险接触者与病例有密切、长时间的接触(≥10 分钟,距离在 2 米以内)。中风险接触者在接触时佩戴所有美国疾病控制与预防中心推荐的个人防护设备。从病例和高风险接触者采集鼻咽和口咽(NP/OP)标本,用于 SARS-CoV-2 检测。

结果

采集了 11 份时间点配对的病例 NP/OP 标本进行 SARS-CoV-2 检测。在 8 对(73%)中,至少有 1 份标本检测阳性或不确定,而在 3 对(27%)中,2 份标本均为阴性。在诊断后 18 天采集的标本检测阳性。确定了 16 名接触者;11 名(69%)有高风险接触,包括 1 名密切接触者,5 名(31%)有中风险接触。共采集了 35 份高风险接触者 NP/OP 标本进行 SARS-CoV-2 检测;35 对(100%)均为阴性。

结论

本报告表明,SARS-CoV-2 感染可引起轻症,且在诊断后 18 天内可检测出阳性,且无密切接触者传播的证据。这些数据可能为管理无症状感染或轻症患者的公共卫生策略提供信息。